[1]
SILVIA, “EFFECTIVENESS OF CHITOSAN NANOPARTICLE CONTAINING 0.7% TETRACYCLINES ON CLINICAL PARAMETERS AND FIBROBLAST GROWTH: FACTOR-2 IN RAT MODELS”, Int J App Pharm, vol. 16, no. 2, pp. 43–50, May 2024.